» Articles » PMID: 40060084

GALNT3 Mutation in Hyperphosphatemic Familial Tumoral Calcinosis - Novel Etiology of Secondary Amyloidosis

Overview
Specialty Nephrology
Date 2025 Mar 10
PMID 40060084
Authors
Affiliations
Soon will be listed here.
Abstract

Tumoral calcinosis is a rare syndrome characterized by calcium salt deposition in different periarticular soft tissue regions. We report this case of tumoral calcinosis with history of persistent soft tissue calcifications for over three decades. He presented with nephrotic syndrome and kidney biopsy revealed secondary amyloidosis. Genetic evaluation revealed GALNT3 mutation and diagnosis of hyperphosphatemic familial tumoral calcinosis was made. With this case report, we want to reiterate the need to consider tumoral calcinosis in secondary amyloidosis differentials and the pivotal role of genetic workup in chronic soft tissue calcifications.

References
1.
Dinur D, Klein Y, Stalnikowicz R, Brezis M . Systemic amyloidosis secondary to tumoral calcinosis. Nephron. 1991; 59(3):525-6. DOI: 10.1159/000186633. View

2.
Papa R, Lachmann H . Secondary, AA, Amyloidosis. Rheum Dis Clin North Am. 2018; 44(4):585-603. DOI: 10.1016/j.rdc.2018.06.004. View

3.
Mumme T, Griefingholt H, Schmidt-Rohlfing B, Muller-Rath R, Kochs A . [Teutschländer disease. A rare benign differential diagnosis of proliferative space-occupying lesions in the periarticular soft tissue]. Orthopade. 2004; 33(7):829-35. DOI: 10.1007/s00132-004-0641-4. View

4.
Chebbi W, Belhaj G, Belhaj Messaoud A . Tumoral calcinosis: a rare disease. Tunis Med. 2021; 99(2):306-310. PMC: 8715796. View

5.
Fathi I, Sakr M . Review of tumoral calcinosis: A rare clinico-pathological entity. World J Clin Cases. 2014; 2(9):409-14. PMC: 4163761. DOI: 10.12998/wjcc.v2.i9.409. View